IRCT20160914029818N3CompletedPhase 3
Clinical trial Study of the effect of Myrtoid and 2% diltiazem with placebo in treatment of complications of chronic anal fissure patients
Bagheiat-allah University of Medical Sciences0 sites99 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 99
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Having at least 2 months of chronic anal fissure
Exclusion Criteria
- •Patients with Crohn's disease
- •Patients with colon cancer
- •Patients with diabetes
- •History of anal surgery
Investigators
Similar Trials
Completed
Phase 2
Study of Effect of Myrtus extract on diabetic foot woundsDiabetic Foot Ulcers.diabetes, With peripheral circulatory complicationsIRCT2016020626394N1Vice chancellor for research, Arak University of Medical Sciences70
Recruiting
Phase 3
Therapeutic effect of mirtazapine with venlafaxine in the treatment of tension headachesIRCT20210410050915N1Esfahan University of Medical Sciences130
Recruiting
Phase 3
Effect of Myrtus communis syrup in treatment of Functional DyspepsiaIRCT20231005059633N1Kermanshah University of Medical Sciences60
Recruiting
Phase 2
Examination of the therapeutic effects of Morita therapy-based group psychotherapy for anxiety and obsessive-compulsive disordersSocial anxiety disorder, Panic disorder, Agoraphobia, Generalized anxiety disorder, Somatic symptom disorder and obsessive-compulsive in the DSM-5.JPRN-UMIN000052652Jikei University School of Medicine10
Unknown
Phase 2
Comparison of Myrtus Communis L. and Descurainia Sophia L. versus salicylic acid in the treatment of wartWart.Viral wartsIRCT2012092710947N1Vice-Chancellor for Research (Tehran University of Medical Sciences)100